Activity of Gemcitabine in Platinum-resistant Ovarian Germ Cell Cancer

By Maas K.   Daikeler T.   Kanz L.   Bokemeyer C.  

European Journal of Cancer, Vol. 32, Iss. 8, 1996-07 ,pp. : 1437-1438

Elsevier

Access to resources Recommend Favorite

Synergistic effects of suberoylanilide hydroxamic acid combined with cisplatin causing cell cycle arrest independent apoptosis in platinum-resistant ovarian cancer cells

By Ong Pei-Shi   Wang Xin-Qiao   Lin Hai-Shu   Chan Sui-Yung   Ho Paul C.  

International Journal of Oncology, Vol. 40, Iss. 5, 2012-05 ,pp. : 1705-1713

Spandidos Publications

Access to resources Recommend Favorite

Platinum retreatment of platinum-resistant ovarian cancer after nonplatinum therapy

By Leitao M.M.   Hummer A.   Dizon D.S.   Aghajanian C.   Hensley M.   Sabbatini P.   Venkatraman E.   Spriggs D.R.  

Gynecologic Oncology, Vol. 91, Iss. 1, 2003-10 ,pp. : 123-129

Elsevier

Access to resources Recommend Favorite

Sustained Complete Remission in a Patient with Platinum-Resistant Ovarian Yolk Sac Tumor

By Jeyakumar A.   Chalas E.   Hindenburg A.  

Gynecologic Oncology, Vol. 82, Iss. 3, 2001-09 ,pp. : 578-580

Elsevier

Access to resources Recommend Favorite

A pilot study of whole body hyperthermia and carboplatin in platinum-resistant ovarian cancer

By Westermann A.M.   Grosen E.A.   Katschinski D.M.   Jager D.   Rietbroek R.   Schink J.C.   Tiggelaar C.L.   Jager E.   Zum Vorde sive Vording P.   Neuman A.   Knuth A.   Van Dijk J.D.P.   Wiedemann G.J.   Robins H.I.  

European Journal of Cancer, Vol. 37, Iss. 9, 2001-06 ,pp. : 1111-1117

Elsevier

Access to resources Recommend Favorite